vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $339.0M, roughly 1.0× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs 4.7%, a 8.5% gap on every dollar of revenue. On growth, APOGEE ENTERPRISES, INC. posted the faster year-over-year revenue change (1.6% vs -2.7%). Over the past eight quarters, APOGEE ENTERPRISES, INC.'s revenue compounded faster (2.9% CAGR vs 0.4%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
APOG vs HAE — Head-to-Head
Income Statement — Q4 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $339.0M |
| Net Profit | $16.6M | $44.7M |
| Gross Margin | 22.4% | 59.7% |
| Operating Margin | 7.3% | 19.9% |
| Net Margin | 4.7% | 13.2% |
| Revenue YoY | 1.6% | -2.7% |
| Net Profit YoY | 568.8% | 19.3% |
| EPS (diluted) | $0.78 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $339.0M | ||
| Q3 25 | $358.2M | $327.3M | ||
| Q2 25 | $346.6M | $321.4M | ||
| Q1 25 | $345.7M | $330.6M | ||
| Q4 24 | $341.3M | $348.5M | ||
| Q3 24 | $342.4M | $345.5M | ||
| Q2 24 | $331.5M | $336.2M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $44.7M | ||
| Q3 25 | $23.6M | $38.7M | ||
| Q2 25 | $-2.7M | $34.0M | ||
| Q1 25 | $2.5M | $58.0M | ||
| Q4 24 | $21.0M | $37.5M | ||
| Q3 24 | $30.6M | $33.8M | ||
| Q2 24 | $31.0M | $38.4M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 59.7% | ||
| Q3 25 | 23.1% | 59.5% | ||
| Q2 25 | 21.7% | 59.8% | ||
| Q1 25 | 21.6% | 58.4% | ||
| Q4 24 | 26.1% | 55.5% | ||
| Q3 24 | 28.4% | 54.2% | ||
| Q2 24 | 29.8% | 52.0% |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 19.9% | ||
| Q3 25 | 7.5% | 17.9% | ||
| Q2 25 | 2.0% | 16.8% | ||
| Q1 25 | 1.8% | 21.6% | ||
| Q4 24 | 8.4% | 16.9% | ||
| Q3 24 | 12.3% | 15.0% | ||
| Q2 24 | 12.5% | 11.8% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 13.2% | ||
| Q3 25 | 6.6% | 11.8% | ||
| Q2 25 | -0.8% | 10.6% | ||
| Q1 25 | 0.7% | 17.5% | ||
| Q4 24 | 6.1% | 10.8% | ||
| Q3 24 | 8.9% | 9.8% | ||
| Q2 24 | 9.4% | 11.4% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.95 | ||
| Q3 25 | $1.10 | $0.81 | ||
| Q2 25 | $-0.13 | $0.70 | ||
| Q1 25 | $0.12 | $1.17 | ||
| Q4 24 | $0.96 | $0.74 | ||
| Q3 24 | $1.40 | $0.66 | ||
| Q2 24 | $1.41 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $363.4M |
| Total DebtLower is stronger | $232.3M | $1.2B |
| Stockholders' EquityBook value | $511.8M | $911.5M |
| Total Assets | $1.1B | $2.5B |
| Debt / EquityLower = less leverage | 0.45× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $363.4M | ||
| Q3 25 | $39.5M | $296.4M | ||
| Q2 25 | $32.8M | $292.9M | ||
| Q1 25 | $41.4M | $306.8M | ||
| Q4 24 | $43.9M | $320.8M | ||
| Q3 24 | $51.0M | $299.3M | ||
| Q2 24 | $30.4M | $344.4M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | $285.0M | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $911.5M | ||
| Q3 25 | $500.2M | $849.2M | ||
| Q2 25 | $481.8M | $882.3M | ||
| Q1 25 | $487.9M | $820.8M | ||
| Q4 24 | $522.1M | $906.9M | ||
| Q3 24 | $506.4M | $878.9M | ||
| Q2 24 | $480.0M | $905.4M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $2.5B | ||
| Q3 25 | $1.2B | $2.4B | ||
| Q2 25 | $1.2B | $2.5B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $1.2B | $2.5B | ||
| Q3 24 | $917.1M | $2.5B | ||
| Q2 24 | $889.0M | $2.5B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | 0.58× | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | 7.8% | 1.9% |
| Cash ConversionOCF / Net Profit | 7.37× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $93.6M | ||
| Q3 25 | $57.1M | $111.3M | ||
| Q2 25 | $-19.8M | $17.4M | ||
| Q1 25 | $30.0M | $116.6M | ||
| Q4 24 | $31.0M | $43.8M | ||
| Q3 24 | $58.7M | $48.8M | ||
| Q2 24 | $5.5M | $-27.4M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $87.2M | ||
| Q3 25 | $52.4M | $106.3M | ||
| Q2 25 | $-26.9M | $13.6M | ||
| Q1 25 | $19.1M | $100.9M | ||
| Q4 24 | $22.0M | $35.2M | ||
| Q3 24 | $50.2M | $39.4M | ||
| Q2 24 | $-1.8M | $-33.1M |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 25.7% | ||
| Q3 25 | 14.6% | 32.5% | ||
| Q2 25 | -7.8% | 4.2% | ||
| Q1 25 | 5.5% | 30.5% | ||
| Q4 24 | 6.4% | 10.1% | ||
| Q3 24 | 14.7% | 11.4% | ||
| Q2 24 | -0.5% | -9.8% |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 1.9% | ||
| Q3 25 | 1.3% | 1.5% | ||
| Q2 25 | 2.1% | 1.2% | ||
| Q1 25 | 3.2% | 4.7% | ||
| Q4 24 | 2.6% | 2.5% | ||
| Q3 24 | 2.5% | 2.7% | ||
| Q2 24 | 2.2% | 1.7% |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | 2.09× | ||
| Q3 25 | 2.41× | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 12.08× | 2.01× | ||
| Q4 24 | 1.48× | 1.17× | ||
| Q3 24 | 1.92× | 1.44× | ||
| Q2 24 | 0.18× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
